FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2096006212> ?p ?o ?g. }

• W2096006212 abstract "Metaplastic breast carcinoma is a rare aggressive malignant neoplasm. The purposes of this study are to review the pathologic features and clinical outcomes of metaplastic breast carcinoma compared to invasive ductal carcinoma and to evaluate the prognosis of metaplastic breast carcinoma.The cases of 55 patients with metaplastic breast carcinoma presenting between 1991 and 2006 were analyzed and compared to the cases of 767 age-matched patients with invasive ductal carcinoma from the same time period.The group of patients with metaplastic breast carcinoma presented with a larger tumor size, lower lymph node involvement, higher percentage of triple-negative (estrogen receptor-, progesterone receptor- and human epidermal growth factor receptor-2-negative) cases, and Ki-67 over-expression compared with the group of patients with invasive ductal carcinoma and triple-negative invasive ductal carcinomas. Patients in the metaplastic breast carcinoma group tended to have more local (often chest wall) recurrences (P = 0.038) and distant (often lung) metastases (P = 0.001) than those in the invasive ductal carcinomas group. The prognosis of metaplastic breast carcinoma was poorer than that of invasive ductal carcinoma and triple-negative invasive ductal carcinomas; the 5-year overall survival rate was 54.5% in metaplastic breast carcinoma versus 85.1% in invasive ductal carcinoma, and 73.3% in triple-negative invasive ductal carcinomas (P <0.001). The 5-year disease-free survival rate was 45.5% in metaplastic breast carcinoma versus 71.2% in invasive ductal carcinoma, and 60.3% in triple-negative invasive ductal carcinomas (P <0.001). Multivariate analysis revealed tumor size larger than 5.0 cm, lymph node involvement and Ki-67≥14% were significantly related to 5-year overall survival (P = 0.010; P = 0.010; P = 0.035) and 5-year disease-free survival (P = 0.020; P = 0.018; P = 0.049).Metaplastic breast carcinoma shows a poorer prognosis than both invasive ductal carcinoma and triple-negative invasive ductal carcinomas. Tumor size larger than 5.0 cm, lymph node involvement and Ki-67 ≥14% indicate a poor prognosis in patients with metaplastic breast carcinoma." @default.
• W2096006212 created "2016-06-24" @default.
• W2096006212 creator A5001547762 @default.
• W2096006212 creator A5004653210 @default.
• W2096006212 creator A5034508417 @default.
• W2096006212 creator A5039845871 @default.
• W2096006212 creator A5046662102 @default.
• W2096006212 creator A5047737377 @default.
• W2096006212 creator A5055912373 @default.
• W2096006212 creator A5068374399 @default.
• W2096006212 creator A5076689560 @default.
• W2096006212 creator A5078684699 @default.
• W2096006212 creator A5084846204 @default.
• W2096006212 creator A5086855515 @default.
• W2096006212 creator A5089882101 @default.
• W2096006212 date "2013-06-06" @default.
• W2096006212 modified "2023-10-14" @default.
• W2096006212 title "Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators" @default.
• W2096006212 cites W1970419458 @default.
• W2096006212 cites W1997730866 @default.
• W2096006212 cites W2002673891 @default.
• W2096006212 cites W2019317235 @default.
• W2096006212 cites W2020291298 @default.
• W2096006212 cites W2027797732 @default.
• W2096006212 cites W2032597244 @default.
• W2096006212 cites W2038630291 @default.
• W2096006212 cites W2052882948 @default.
• W2096006212 cites W2054961739 @default.
• W2096006212 cites W2059303218 @default.
• W2096006212 cites W2098441767 @default.
• W2096006212 cites W2123069002 @default.
• W2096006212 cites W2127057139 @default.
• W2096006212 cites W2130900820 @default.
• W2096006212 cites W2137853125 @default.
• W2096006212 cites W2145613493 @default.
• W2096006212 cites W2151078130 @default.
• W2096006212 cites W2152846413 @default.
• W2096006212 cites W2160928966 @default.
• W2096006212 cites W2340301267 @default.
• W2096006212 cites W2612817634 @default.
• W2096006212 doi "https://doi.org/10.1186/1477-7819-11-129" @default.
• W2096006212 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3679991" @default.
• W2096006212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23738706" @default.
• W2096006212 hasPublicationYear "2013" @default.
• W2096006212 type Work @default.
• W2096006212 sameAs 2096006212 @default.
• W2096006212 citedByCount "110" @default.
• W2096006212 countsByYear W20960062122013 @default.
• W2096006212 countsByYear W20960062122014 @default.
• W2096006212 countsByYear W20960062122015 @default.
• W2096006212 countsByYear W20960062122016 @default.
• W2096006212 countsByYear W20960062122017 @default.
• W2096006212 countsByYear W20960062122018 @default.
• W2096006212 countsByYear W20960062122019 @default.
• W2096006212 countsByYear W20960062122020 @default.
• W2096006212 countsByYear W20960062122021 @default.
• W2096006212 countsByYear W20960062122022 @default.
• W2096006212 countsByYear W20960062122023 @default.
• W2096006212 crossrefType "journal-article" @default.
• W2096006212 hasAuthorship W2096006212A5001547762 @default.
• W2096006212 hasAuthorship W2096006212A5004653210 @default.
• W2096006212 hasAuthorship W2096006212A5034508417 @default.
• W2096006212 hasAuthorship W2096006212A5039845871 @default.
• W2096006212 hasAuthorship W2096006212A5046662102 @default.
• W2096006212 hasAuthorship W2096006212A5047737377 @default.
• W2096006212 hasAuthorship W2096006212A5055912373 @default.
• W2096006212 hasAuthorship W2096006212A5068374399 @default.
• W2096006212 hasAuthorship W2096006212A5076689560 @default.
• W2096006212 hasAuthorship W2096006212A5078684699 @default.
• W2096006212 hasAuthorship W2096006212A5084846204 @default.
• W2096006212 hasAuthorship W2096006212A5086855515 @default.
• W2096006212 hasAuthorship W2096006212A5089882101 @default.
• W2096006212 hasBestOaLocation W20960062121 @default.
• W2096006212 hasConcept C121608353 @default.
• W2096006212 hasConcept C126322002 @default.
• W2096006212 hasConcept C142724271 @default.
• W2096006212 hasConcept C143998085 @default.
• W2096006212 hasConcept C2776047466 @default.
• W2096006212 hasConcept C2777546739 @default.
• W2096006212 hasConcept C2780140570 @default.
• W2096006212 hasConcept C2780862961 @default.
• W2096006212 hasConcept C3018521938 @default.
• W2096006212 hasConcept C530470458 @default.
• W2096006212 hasConcept C71924100 @default.
• W2096006212 hasConceptScore W2096006212C121608353 @default.
• W2096006212 hasConceptScore W2096006212C126322002 @default.
• W2096006212 hasConceptScore W2096006212C142724271 @default.
• W2096006212 hasConceptScore W2096006212C143998085 @default.
• W2096006212 hasConceptScore W2096006212C2776047466 @default.
• W2096006212 hasConceptScore W2096006212C2777546739 @default.
• W2096006212 hasConceptScore W2096006212C2780140570 @default.
• W2096006212 hasConceptScore W2096006212C2780862961 @default.
• W2096006212 hasConceptScore W2096006212C3018521938 @default.
• W2096006212 hasConceptScore W2096006212C530470458 @default.
• W2096006212 hasConceptScore W2096006212C71924100 @default.
• W2096006212 hasIssue "1" @default.
• W2096006212 hasLocation W20960062121 @default.
• W2096006212 hasLocation W20960062122 @default.
• W2096006212 hasLocation W20960062123 @default.
• W2096006212 hasLocation W20960062124 @default.

• next